Trials / Completed
CompletedNCT00927979
Pain Relief by Intra-Peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia for Gynecological Laparoscopy
Phase 3 Prospective, Randomized, Controlled and Double-blinded Second Trial on Pain Relief by Continuous Intra-peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia, During Gynecological Laparoscopic Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Carmel Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecologic laparoscopic surgery. This is a second steady with protocol of general anesthesia used of Remifentanil.
Detailed description
Outcome Measures : * VAS score * Use of analgesics during operation and postoperative period
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 10 mLRopivacaine 1% | Intraperitoneal nebulization of 10 mL Ropivacaine 1% |
| DRUG | Water for injection | Intraperitoneal nebulization of 10 mL water for injection |
| DRUG | 10 mL Ropivacaine 1% | Intraperitoneal nebulization of 10 mL Ropivacaine 1% |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-07-01
- Completion
- 2010-10-01
- First posted
- 2009-06-25
- Last updated
- 2011-06-28
Source: ClinicalTrials.gov record NCT00927979. Inclusion in this directory is not an endorsement.